Literature DB >> 30306321

Metformin attenuates increase of synaptic number in the rat spinal dorsal horn with painful diabetic neuropathy induced by type 2 diabetes: a stereological study.

Jing-Yan Lin1, Yi-Na He1,2, Na Zhu1, Bin Peng3.   

Abstract

In our previous study, we have shown that number of synapses in the L5 segment of spinal dorsal horn increased significantly in a rat model of painful diabetic neuropathy (PDN) induced by high-dose of streptozotocin (an animal model of type 1 diabetes). The aims of this study were: (1) to determine whether high fat diet/low dose streptozotocin-diabetes, a rat model for type 2 diabetes, related PDN was also associated with this synaptic plasticity, (2) to reveal the range of this synaptic plasticity change occurred (in the whole length of spinal dorsal horn or only in the L5 lumbar segment of spinal dorsal horn) and (3) to discover whether treatment with metformin had effect on this synaptic plasticity. Male adult Sprague-Dawley rats were randomly allocated into the control group (n = 7), the PDN group (n = 6) and the PDN treated with metformin (PDN + M) group (n = 7), respectively. 28 days after medication, synaptic and neuronal numbers in the whole length of spinal dorsal horn or in 1 mm length of the L5 segment of spinal dorsal horn were estimated by the optical disector (a stereological technique). Compared to the control group and the PDN + M group, number of synapses in the L5 segment of spinal dorsal horn increased significantly in the PDN group (P < 0.05). There was no significant change between the control group and the PDN + M group in terms of the parameters in the L5 segment of the spinal dorsal horn (P > 0.05). Parameters of the whole length of spinal dorsal horn showed no significant changes (P > 0.05). Our results suggest that high fat diet/low dose streptozotocin diabetes related PDN is also associated with a numerical increase of synapses in the L5 segment of spinal dorsal horn but not in the whole length of spinal dorsal horn. Furthermore, the analgesic effect of metformin against PDN is related to its inhibition of numerical increase of synaptic number in the rat spinal dorsal horn.

Entities:  

Keywords:  Diabetes mellitus; Metformin; Neuropathic pain; Optical disector; Stereology; Synaptic plasticity

Mesh:

Substances:

Year:  2018        PMID: 30306321     DOI: 10.1007/s11064-018-2642-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats.

Authors:  Shao-Rui Chen; Hui-Lin Pan
Journal:  J Neurophysiol       Date:  2002-06       Impact factor: 2.714

2.  Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin.

Authors:  Junxiong Ma; Hailong Yu; Jun Liu; Yu Chen; Qi Wang; Liangbi Xiang
Journal:  Eur J Pharmacol       Date:  2015-06-06       Impact factor: 4.432

3.  Plasticity in the synaptic number associated with neuropathic pain in the rat spinal dorsal horn: A stereological study.

Authors:  Bin Peng; Jing-Yan Lin; Yi Shang; Zheng-Wei Yang; Ya-Ping Wang
Journal:  Neurosci Lett       Date:  2010-09-19       Impact factor: 3.046

4.  Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain.

Authors:  Xiao-Peng Mei; Yang Zhou; Wei Wang; Jun Tang; Wen Wang; Hui Zhang; Li-Xian Xu; Yun-Qing Li
Journal:  Neurosignals       Date:  2011-03-09

5.  Stereological study on the number of synapses in the rat spinal dorsal horn with painful diabetic neuropathy induced by streptozotocin.

Authors:  Jing-Yan Lin; Xiao-Li Huang; Jing Chen; Zheng-Wei Yang; Jing Lin; San Huang; Bin Peng
Journal:  Neuroreport       Date:  2017-04-12       Impact factor: 1.837

6.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

Authors:  P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

7.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

8.  Activation of the AMP-activated protein kinase reduces inflammatory nociception.

Authors:  Otto Quintus Russe; Christine V Möser; Katharina L Kynast; Tanya S King; Heike Stephan; Gerd Geisslinger; Ellen Niederberger
Journal:  J Pain       Date:  2013-07-31       Impact factor: 5.820

9.  Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.

Authors:  Caroline A Abbott; Rayaz A Malik; Ernest R E van Ross; Jai Kulkarni; Andrew J M Boulton
Journal:  Diabetes Care       Date:  2011-08-18       Impact factor: 19.112

10.  Proteomic and functional annotation analysis of injured peripheral nerves reveals ApoE as a protein upregulated by injury that is modulated by metformin treatment.

Authors:  Ohannes K Melemedjian; Hussein N Yassine; Adia Shy; Theodore J Price
Journal:  Mol Pain       Date:  2013-03-26       Impact factor: 3.395

View more
  10 in total

1.  Upregulation of TLR9 may contribute to activation of microglia and painful diabetic neuropathy via the p38 MAPK pathway in rats.

Authors:  Zhaoxia Niu; Lei Bao; Jing Chen
Journal:  Histol Histopathol       Date:  2021-12-10       Impact factor: 2.303

Review 2.  Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?

Authors:  Moein Ala; Mahan Ala
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-01

Review 3.  Metformin: A Prospective Alternative for the Treatment of Chronic Pain.

Authors:  Guadalupe Del Carmen Baeza-Flores; Crystell Guadalupe Guzmán-Priego; Leonor Ivonne Parra-Flores; Janet Murbartián; Jorge Elías Torres-López; Vinicio Granados-Soto
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

Review 4.  Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.

Authors:  Snježana Radulović; Sowmya Sunkara; Christa Maurer; Gerd Leitinger
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

Review 5.  Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions.

Authors:  Md Jakir Hossain; Michael D Kendig; Meg E Letton; Margaret J Morris; Ria Arnold
Journal:  Diabetes Metab J       Date:  2022-03-24       Impact factor: 5.893

6.  β-Hydroxybutyrate Attenuates Painful Diabetic Neuropathy via Restoration of the Aquaporin-4 Polarity in the Spinal Glymphatic System.

Authors:  Fei-Xiang Wang; Chi-Liang Xu; Can Su; Jiang Li; Jing-Yan Lin
Journal:  Front Neurosci       Date:  2022-07-11       Impact factor: 5.152

7.  Plasticity of the spinal glymphatic system in male SD rats with painful diabetic neuropathy induced by type 2 diabetes mellitus.

Authors:  Guo-Qiang Wang; Fei-Xiang Wang; Yi-Na He; Jing-Yan Lin
Journal:  J Neurosci Res       Date:  2022-07-07       Impact factor: 4.433

8.  Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior.

Authors:  Hui Li; Xiang Ding; Robert Terkeltaub; Hang Lin; Yuqing Zhang; Bin Zhou; Ke He; Kun Li; Zhichen Liu; Jie Wei; Yuanheng Yang; Hui Xie; Chao Zeng; Guanghua Lei
Journal:  Arthritis Res Ther       Date:  2020-02-22       Impact factor: 5.156

9.  Stereological study on the numerical plasticity of myelinated fibers and oligodendrocytes in the rat spinal cord with painful diabetic neuropathy.

Authors:  Jing-Yan Lin; Na Zhu; Yi-Na He; Bo-Lin Xu; Bin Peng
Journal:  Neuroreport       Date:  2020-03-04       Impact factor: 1.703

10.  Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system.

Authors:  Sarah Demaré; Asha Kothari; Nigel A Calcutt; Paul Fernyhough
Journal:  Expert Rev Neurother       Date:  2020-12-04       Impact factor: 4.287

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.